Addus HomeCare Corporation logo

Addus HomeCare Corporation (ADUS)

Market Closed
23 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
117. 63
+2.15
+1.86%
$
2.13B Market Cap
- P/E Ratio
- Div Yield
323,257 Volume
- Eps
$ 115.48
Previous Close
Day Range
113.66 118.22
Year Range
88.96 124.44
Want to track ADUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ADUS earnings report is expected in 6 days (2 Mar 2026)
All You Need to Know About Addus HomeCare (ADUS) Rating Upgrade to Buy

All You Need to Know About Addus HomeCare (ADUS) Rating Upgrade to Buy

Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 year ago
ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS or USPH: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 1 year ago
4 Stocks That Flaunt an Impressive Interest Coverage Ratio

4 Stocks That Flaunt an Impressive Interest Coverage Ratio

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. HALO, LDOS, ATO & ADUS are sound enough to meet financial obligations.

Zacks | 1 year ago
Addus HomeCare (ADUS) Reports Q2 Earnings: What Key Metrics Have to Say

Addus HomeCare (ADUS) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.07 per share a year ago.

Zacks | 1 year ago
ADUS vs. CHE: Which Stock Is the Better Value Option?

ADUS vs. CHE: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
4 Stocks to Watch From a Challenging Outpatient Home Health Industry

4 Stocks to Watch From a Challenging Outpatient Home Health Industry

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.

Zacks | 1 year ago
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
3 Small-Cap Stocks Ready to Deliver Jumbo-Sized Gains

3 Small-Cap Stocks Ready to Deliver Jumbo-Sized Gains

On Wall Street, small-cap stocks often present unique opportunities for significant growth. These under-the-radar companies are typically not as well-known or widely covered by analysts as their large-cap counterparts.

Investorplace | 1 year ago